Your search returned 8 results.

Results
	1.	Response of psoriasis to a new topical retinoid, AGN 190168. [electronic resource] by Esgleyes-Ribot, T Chandraratna, R A Lew-Kaya, D A Sefton, J Duvic, M Producer: 19940518 In: Journal of the American Academy of Dermatology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Tazarotene plus UVB phototherapy in the treatment of psoriasis. [electronic resource] by Koo, J Y Lowe, N J Lew-Kaya, D A Vasilopoulos, A I Lue, J C Sefton, J Gibson, J R Producer: 20010405 In: Journal of the American Academy of Dermatology vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis. [electronic resource] by Krueger, G G Drake, L A Elias, P M Lowe, N J Guzzo, C Weinstein, G D Lew-Kaya, D A Lue, J C Sefton, J Chandraratna, R A Producer: 19980217 In: Archives of dermatology vol. 134 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis. [electronic resource] by Jordon, R E Rapini, R P Rex, I H Katz, H I Hickman, J G Bard, J W Medansky, R S Lew-Kaya, D A Sefton, J DeGryse, R E Producer: 19901012 In: International journal of dermatology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. [electronic resource] by Kang, S Leyden, J J Lowe, N J Ortonne, J P Phillips, T J Weinstein, G D Bhawan, J Lew-Kaya, D A Matsumoto, R M Sefton, J Walker, P S Gibson, J R Producer: 20020108 In: Archives of dermatology vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study. [electronic resource] by Shalita, A R Chalker, D K Griffith, R F Herbert, A A Hickman, J G Maloney, J M Miller, B H Tschen, E H Chandraratna, R A Gibson, J R Lew-Kaya, D A Lue, J C Sefton, J Producer: 19990913 In: Cutis vol. 63 Availability: No items available. Save to lists Add to cart (remove)
	7.	Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. [electronic resource] by Lebwohl, M G Breneman, D L Goffe, B S Grossman, J R Ling, M R Milbauer, J Pincus, S H Sibbald, R G Swinyer, L J Weinstein, G D Lew-Kaya, D A Lue, J C Gibson, J R Sefton, J Producer: 19981104 In: Journal of the American Academy of Dermatology vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. [electronic resource] by Weinstein, G D Krueger, G G Lowe, N J Duvic, M Friedman, D J Jegasothy, B V Jorizzo, J L Shmunes, E Tschen, E H Lew-Kaya, D A Lue, J C Sefton, J Gibson, J R Chandraratna, R A Producer: 19970804 In: Journal of the American Academy of Dermatology vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)